The highly diverse T-cell receptor (TCR) repertoire of T lymphocytes is important in most adaptive immune responses. Although most TCRs are highly specific for a given peptide-major histocompatibilty complex (pMHC), the affinity of this interaction is low 1 , and thus multimeric pMHC staining reagents are needed for the specific detection, characterization and isolation of antigen specific cells using flow cytometry 2 . T-cell responses to autoantigens, infectious diseases and tumor cells have all been analyzed with these reagents [3] [4] [5] [6] . Recently, several different peptide exchange protocols have allowed rapid production of pMHC tetramers displaying, in at least one case, thousands of different peptides [7] [8] [9] [10] . But there is currently no way to efficiently deploy more than a few tetramers when sample size is limited. This is especially true with clinical specimens, where one often has only one or a few million T cells per time point in a standard blood draw, enough for one or at most a few flow-cytometrical analyses.
Here we describe and validate a method that allows the simultaneous use of large numbers of different pMHC tetramers on small numbers of cells using standard flow cytometry and reagents. This method makes use of fluorescently tagged strepavidin backbones to create pMHC tetramers that use all possible combinations of fluorophores, similar to an approach described for use with antibody combinations 11 . The number of different T-cell specificities that can be detected equals 2 N -1, where N is the number of different fluorescent labels. Here we use four strepavidin 'colors' to detect the predicted 15 different T-cell specificities, but we also performed experiments using five and six colors, suggesting that 31 and 63 specificities, respectively, are also achievable.
As a first test for this approach, we stained peripheral blood mononuclear cells (PBMCs) from a donor with B0.07% cytomegalovirus (CMV) dominant epitope pp65-CMV/human leukocyte antigen (HLA)-A0201-specific CD8 + T cells, with 15 different color combinations of the pp65-CMV/HLA-A0201 tetramer (defined here as 'CMV tetramer'), using four different commercially available fluorescent streptavidin species (phycoerythrin (PE), PE-Cy5, PECy7 and allophycocyanin (APC) conjugates). First, we split the sample into 15 aliquots and stained separately with 15 different color combinations of this tetramer. Then we washed the cells, mixed them together and analyzed them on an LSRII flow cytometer (BD Bioscience; Stanford Shared fluorescence-activated cell sorting (FACS) Facility) ( (Fig. 1f) . To test the limitations of this system, we used another CMV-seropositive blood sample and quadruple stained it with PE-, PE-Cy5-, PE-Cy7-and APC-labeled CMV tetramers. In separate wells, we also stained these cells with all possible combinations of PE-Cy5.5-and APC-Cy7-labeled CMV tetramers (four combinations). We washed the cells and then mixed them together. The additional two tetramer colors could be differentiated even when they were used simultaneously with the four other tetramer colors used throughout this study (Fig. 1g) .
We then tested the approach further by making a mixture of pMHC tetramers using HLA-A0201 bound to 15 different peptides. Using a premixed cocktail of tetramers is convenient because it reduces pipeting error and allows for accurate comparisons of various cell samples. We mixed the tetramers together and used them to stain the cells simultaneously (Online Methods). In all cases, we used a hepatitis C virus (HCV) peptide as a negativecontrol or 'dump' peptide for preparing the tetramer labeled with all four fluorophores ( Supplementary Tables 1 and 2 ). In this way, cells nonspecifically stained with all four colors would be eliminated from subsequent analysis. An HCV peptide was appropriate for this purpose because all samples used were HCV-seronegative (as determined by the Stanford Blood Center).
For each combinatorial staining experiment we used a different set and order of peptide epitopes (combinatorial 'schemes' A-D). For this example, the order of the 15 epitopes is listed in Supplementary Table 2 using scheme A. For this particular donor blood sample, we detected six specificities of T cells with a frequency above 0.01% of CD8 + cells. These were the pp65-CMV epitope, three different Epstein-Barr virus (EBV) epitopes, the influenza M1 50-58 epitope and the characterized mutant Mart1a epitope (Supplementary Table 2 and Fig. 1h-l) .
As with all pMHC-tetramer staining experiments, it is critical to define appropriate criteria for setting positive staining thresholds. This can be complicated by the use of multiple fluorophores, each with variable staining intensities, making it necessary to choose arbitrary thresholds. Therefore, we used multiple approaches to verify the identities of tetramer-stained cells and thus to validate the specificity of our staining. In one approach, we stained an aliquot of the same sample with the same set of pMHC tetramers using an alternate color-coding scheme (scheme B; Supplementary Fig. 2 ). The two staining schemes gave very similar results (Fig. 2a) . In another approach, we tested for the disappearance of each T-cell specificity caused by antigen-dependent TCR downregulation in response to peptide-specific interaction with pulsed antigen presenting cells. We pulsed HLA-A0201 + T2 antigen presenting cells in 15 separate wells with a single peptide overnight, and then added T cells for a 5-h incubation. We then stained with the combinatorial cocktail of pMHC tetramers. Each peptide caused a loss of signal for the appropriate peptide specificity (Fig. 2b ). An additional control for nonspecific tetramer staining is to use a 'sham' pMHC tetramer cocktail, containing only the negative-control epitope pMHC species made in parallel and used on a separate aliquot of the same sample ( Supplementary Fig. 3 ).
To compare the sensitivity of the combinatorial approach to the classical approach, we used samples from four donors and split each of them into 18 aliquots. In the first 15, we stained each T-cell specificity separately using the classical approach (a separate PE tetramer for each of the 15 peptides tested and a PE-Cy7-labeled HIV peptide negative-control tetramer). In the other three aliquots, we used identical but separately prepared combinatorial tetramer cocktails (all using peptide scheme C; Supplementary Table 2) . We calculated the percentage of tetramer-positive CD8 + T cells based on by-eye thresholds and compared the values obtained using the two approaches (Fig. 2c) ; we found that the two approaches gave very comparable results above a 0.01% frequency threshold.
Others have shown that magnetic beads coated with antibody to PE can very efficiently enrich for pMHC tetramer-positive cells to allow the detection of exceedingly rare T-cell populations, including naive T-cell populations 8, 12, 13 (1) 
( 1 5 (5) (6) (h-l) Flow cytometry scatter plots of blood samples processed and tetramer-stained using a prepared cocktail of 15 different pMHC specificities represented by combinations of PE-, PE-Cy5-, PE-Cy7-and APC-conjugated streptavidins (scheme A; Supplementary Table 2) . Cells were gated on PE and APC fluorescence (h) into populations labeled i-iv, each of which was fractionated based on its PE-Cy5 and PE-Cy7 fluorescence (i-l, respectively).
combinatorial staining approach can be used in conjunction with this type of enrichment, we first stained cells with the 15 tetramer combinatorial cocktail and then used a mixture of magnetic particles coated with antibodies to PE or antibodies to APC to enrich the sample for tetramer-stained T cells, as described 12 . Using this method, we saw a B100-fold increase in percentages of tetramer-positive cells compared to a preenrichment sample, which is consistent with our previous experience using single or double tetramer stains. Although independent verification of the identities of these populations is beyond the scope of this study, this procedure also revealed several populations of T cells specific for one EBV epitope (EBV4) and three influenza epitopes (flu2, 3 and 5) that were below the threshold of detection without enrichment ( Fig. 2d and Supplementary Figs. 4 and 5) . Using mixing experiments we also verified the accuracy of the enrichment protocol for all fluorophore combinations ( Supplementary  Figs. 6 and 7) .
Here we described a method that uses all possible combinations of four different pMHC labels to detect 15 different ab Tlymphocyte specificities. We extended this method to encompass more colors and many more combinations of colors. So far, we stained cells simultaneously with 6 colors using PE-Cy5.5 and APC-Cy7 streptavidins ( Fig. 1g and Supplementary Fig. 1) , which allows the detection of up to 63 possible specificities. We had much less success with other commercially available streptavidins tested, which varied substantially from lot to lot in staining quality. These problems could be caused by variations in the number of biotin binding sites 14 . Use of a strepavidin mutant that allows site-specific fluorophore labeling has been reported 14 to remedy this problem and should allow the use of several more colors in the combinatorial approach described here. One limitation of our method is the dilution of staining signal by the number of different fluorophores used to stain the same cell. Although we have seen only a 2-3-fold reduction in signal strength per color in the four-color stains ( Supplementary Fig. 3a ), this will certainly become more of a problem as more colors are used. Coupling streptavidin with molecular conjugates containing various combinations of fluorophores and/or quantum dots could solve this problem.
In addition to the utitilty of this approach for probing many peptide specificities bound to a single MHC allele (as demonstrated for HLA-A2), it is also well suited for probing mixtures of several different MHC class I and class II alleles, each bound to various peptide epitopes. This is particularly useful for non-HLA selected human samples, in which there are many different possible alleles. Apropos of this, photocleavable peptides for several other MHC class I alleles have recently been characterized 15 .
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturemethods/.
Note: Supplementary information is available on the Nature Methods website. Table 2 ) or stained with three separate preparations of combinatorial pMHC tetramer cocktails (Supplementary Table 2 Table 2 ). PE5, PE-Cy5; PE7, PE-Cy7. Negatives, tetramer-negative cells.
ONLINE METHODS
Preparation of 15 different streptavidin color combinations. To discern 15 different pMHC tetramer specificities, four fluorescently labeled streptavidins (SAv) were purchased from eBioscience (PE-SAv, ''P''; PECy5-SAv, ''P5''; PECy7-SAv, ''P7''; and APC-SAv, ''A'') and mixed to create the 15 different staining combinations. These streptavidins were mixed and adjusted with PBS to make a final volume of 95 ml (Supplementary Table 1 ). For the lots used in this study, the relative ratios of each color were empirically determined. For instance, a higher APC-SAv molar ratio was used because it generally had a lower fluorescent signal than the other dyes when used at equal molar concentration.
Biotinylated HLA-A2 protein peptide exchange. To produce the various biotinylated pMHC molecules, HLA-A2 was refolded with a UV-light-cleavable peptide, biotinylated and purified as described 7 . After purification, the protein stock was stored in 50% glycerol at À20 1C. For each peptide specificity, peptide exchange reactions were set up in 100-ml volumes each containing 10 mM peptide and 100 mg ml -1 HLA-A2 protein in PBS (pH 7.2). After a 20 min exposure to 365 nm UV-light irradiation using a Stratagene UV Stratalinker 2400, the protein was stored at 4 1C overnight to complete the exchange. To remove aggregates, the protein was then centrifuged at 5,000g for 5 min and 90 ml of protein was transferred to a new plate.
Tetramerization. After UV-light exchange to create 15 different biotinylated pMHC monomers in separate wells, the streptavidin mixtures described above were added incrementally to achieve 4 4:1 pMHC:SAv molar ratio. In all cases, the combination number 15 was used as a 'dump' (negative control) to remove 'sticky' cells. The HCV peptide was used for the dump tetramer. To improve our signal-to-noise ratio and prevent subsequent pMHC crosspairing, streptavidin agarose was added to each tetramer to quench any unbound, biotinylated pMHC. This agarose was removed by filtration. Next, biotinylated agarose was added and filtered out to remove any unsaturated strepavidin molecules. Before mixing all 15 tetramer preparations together, excess free biotin was added to fully quench any unsaturated streptavidin. The tetramer mixtures were then concentrated and exchanged using a 4 ml 10 kDa cut-off Amicon Ultra (Millipore) protein concentrator. Finally, 10 mM HCV peptide was added to the mixture to prevent peptide exchange between the tetramer specificities. Mixtures were stored at 4 1C for later use. For consistency purposes, the optical density at 565 nm was used to ensure that similar concentrations of tetramer mixtures were used in each experiment. The tetramer mixures were diluted when added to the cells to achieve a final OD at 565 nm of 0.5 (corresponding to a final total PE concentration of B250 nM).
Cells and staining. Platelet donor aphaeresis lymphocytes were obtained from the Stanford Blood Center and enriched for CD8 + T cells by negative selection using the human CD8 + T cell Rosettesep enrichment kit (StemCell Technologies). In all cases, tetramer staining was done in PBS with 2 mM EDTA, 2% fetal calf serum, 0.1% sodium azide and 1 mg ml -1 purified antibody to CD16 and antibody to CD32 (eBioscience) for 1 h at room temperature (18-22 1C). Fifteen combinations of PE-, PE-Cy5-, PE-Cy7-and APC-streptavidin were used to make separate preparations of CMV tetramer of each color combination. The cells were subsequently stained on ice with various fluorescent markers, always including CD8 (QDot 605 or 705 (Invitrogen) or PerCP-Cy5.5 anti-CD8 (eBioscience)) and an amine-reactive viability stain (Live/dead Fixable aqua dead cell stain kit; Invitrogen).
